COMMUNIQUÉS West-GlobeNewswire

Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market

14/08/2018 - 15:00

Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products SALT LAKE CITY, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB:NUMD), a medical device leader [...]

Press Release: Juha Tuominen, Chief Medical Officer of Terveystalo, has been elected as the Managing Director of Hospital District of Helsinki and Uusimaa

14/08/2018 - 14:46

According to the public announcement of HUS, the Hospital District of Helsinki and Uusimaa, Juha Tuominen (Professor, MD, Ph.D), Chief Medical Officer of Terveystalo, has been elected as the new Managing Director of HUS [...]

Viveve Initiates LIBERATE-International Trial for Improvement of Stress Urinary Incontinence

14/08/2018 - 14:28

Company also receives regulatory clearance in Argentina for treatment of urinary incontinence Confirms intent to submit IDE to FDA for LIBERATE-U.S. in the third quarter ENGLEWOOD, Colo., Aug. 14, 2018 (GLOBE NEWSWIRE [...]

BioSig Technologies Announces FDA 510(k) Clearance for PURE EP System

14/08/2018 - 14:07

Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug [...]

Spero Announces Appointment of John C. Pottage, Jr., MD to its Board of Directors

14/08/2018 - 14:00

Spero adds broad leadership and scientific expertise to its Board of Directors with appointment of John Pottage CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset [...]

NanoMedical Systems Receives $3M Grant to Advance nStrada™ Implantable Nanofluidics System for Long-Term Treatment of Opioid Use Disorder

14/08/2018 - 14:00

AUSTIN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- NanoMedical Systems, Inc. (NMS), an Austin-based company developing implantable, sustained-release, drug-delivery devices based on its nStrada™ nanofluidics platform has [...]

Timothy Keeler, BS-PA is Selected to the American Health Council’s Board of Physicians

14/08/2018 - 14:00

NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Timothy Keeler, BS-PA to its Board of Physicians. Mr. Keeler currently holds various leadership roles, including vice-president of [...]

Galectin Therapeutics Reports 2018 Second Quarter Financial Results and Provides Business Update

14/08/2018 - 14:00

NORCROSS, Ga., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results for its second fiscal [...]

Spectral Announces Second Quarter Results

14/08/2018 - 14:00

TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]

Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies

14/08/2018 - 14:00

MINNEAPOLIS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection

14/08/2018 - 14:00

HIV Trial Will Be Fully Funded by $6.9 Million National Institutes of Health Grant PLYMOUTH MEETING, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that the first [...]

Genacol Canada Corporation and Tetra Bio-Pharma Team Up to bring Innovative Cannabinoid Treatments to Self-Care Market in Canada

14/08/2018 - 14:00

ORLEANS, Ontario, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that they have concluded [...]

Genacol Canada Corporation et Tetra Bio-Pharma s'associent pour introduire des traitements innovants aux cannabinoïdes dans le marché des soins auto-administrés au Canada

14/08/2018 - 14:00

ORLEANS, Ontario, 14 août 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., un chef de file dans la découverte et le développement de médicaments à base de cannabinoïdes (TSX VENTURE: TBP) (OTCQB: TBPMF), est heureuse d’ [...]

Imagin Medical Reports Fiscal 2018 Third Quarter Results

14/08/2018 - 14:00

VANCOUVER, B.C. and BOSTON, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today reported financial results for the three months [...]

Cue Biopharma to Host Investor Business Update Call and Webcast

14/08/2018 - 14:00

Update on progress of selective immune modulation platform CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary [...]

Onconova Therapeutics Reports Business Highlights and Financial Results for Second Quarter 2018

14/08/2018 - 14:00

NEWTOWN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3 stage biopharmaceutical company focused on developing rigosertib, a novel small molecule drug candidate to treat [...]

CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September

14/08/2018 - 14:00

NEWARK, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

14/08/2018 - 14:00

Request for Type A meeting was granted by the U.S. Food and Drug Administration to discuss the Complete Response Letter received in June 2018 Balance sheet remains strong with over $100 million in cash BURLINGTON, Mass [...]

CLS Holdings USA Issues Chairman’s Update

14/08/2018 - 14:00

Seeking Expansion Beyond Nevada Exploring to License the Proprietary Extraction and Conversion Processing LAS VEGAS, Aug. 14, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis [...]